Cargando…

Long-term Visual and Refractive Outcomes of Argon Laser-treated Retinopathy of Prematurity

PURPOSE: In this case–control study, we measured visual acuity, objective refraction, ocular biometric parameters, and strabismus in premature cases classified according to the following categories: argon laser-treated retinopathy of prematurity (ROP), untreated spontaneously regressed ROP, no ROP,...

Descripción completa

Detalles Bibliográficos
Autores principales: Farvardin, Majid, Kalantari, Zahra, Talebnejad, Mohammadreza, Alamolhoda, Marzieh, Norouzpour, Amir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PUBLISHED BY KNOWLEDGE E 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9493422/
https://www.ncbi.nlm.nih.gov/pubmed/36160100
http://dx.doi.org/10.18502/jovr.v17i3.11576
_version_ 1784793715329466368
author Farvardin, Majid
Kalantari, Zahra
Talebnejad, Mohammadreza
Alamolhoda, Marzieh
Norouzpour, Amir
author_facet Farvardin, Majid
Kalantari, Zahra
Talebnejad, Mohammadreza
Alamolhoda, Marzieh
Norouzpour, Amir
author_sort Farvardin, Majid
collection PubMed
description PURPOSE: In this case–control study, we measured visual acuity, objective refraction, ocular biometric parameters, and strabismus in premature cases classified according to the following categories: argon laser-treated retinopathy of prematurity (ROP), untreated spontaneously regressed ROP, no ROP, and full-term controls. METHODS: Cases with a history of prematurity at six years of age were categorized into the following groups: patients with a history of treated type 1 ROP using argon laser (group I), untreated spontaneously regressed ROP (group II), and no history of ROP (group III). Group IV included age-matched healthy full-term controls. Funduscopy was performed for all the cases and the control group. RESULTS: In total, 24 eyes of 12 laser-treated ROP cases, 186 eyes of 93 spontaneously regressed ROP patients, 74 eyes of 37 premature cases with no history of ROP, and 286 eyes of 143 controls were included in the study. The mean spherical equivalent in the treated cases was not significantly different from that in the untreated cases and patients in group III. However, the average cylindrical power was significantly different among the groups (P [Formula: see text] 0.004). Furthermore, anisometropia ( [Formula: see text] 1.5 diopters) was diagnosed with a higher rate in the treated cases (P = 0.03). The corneal curvature of the laser-treated eyes was significantly steeper and the axial length was significantly shorter than those in the other groups (P [Formula: see text] 0.002 and P [Formula: see text] 0.001, respectively, for multivariate analysis). Strabismus was found in three treated patients (25%). Additionally, there were three treated eyes (12.5%) diagnosed with macular dragging. CONCLUSION: Premature cases including those who had a history of argon laser-treated ROP and those with untreated spontaneously regressed ROP showed acceptable long-term visual and refractive outcomes along with a fairly low rate of ocular disorders.
format Online
Article
Text
id pubmed-9493422
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher PUBLISHED BY KNOWLEDGE E
record_format MEDLINE/PubMed
spelling pubmed-94934222022-09-23 Long-term Visual and Refractive Outcomes of Argon Laser-treated Retinopathy of Prematurity Farvardin, Majid Kalantari, Zahra Talebnejad, Mohammadreza Alamolhoda, Marzieh Norouzpour, Amir J Ophthalmic Vis Res Original Article PURPOSE: In this case–control study, we measured visual acuity, objective refraction, ocular biometric parameters, and strabismus in premature cases classified according to the following categories: argon laser-treated retinopathy of prematurity (ROP), untreated spontaneously regressed ROP, no ROP, and full-term controls. METHODS: Cases with a history of prematurity at six years of age were categorized into the following groups: patients with a history of treated type 1 ROP using argon laser (group I), untreated spontaneously regressed ROP (group II), and no history of ROP (group III). Group IV included age-matched healthy full-term controls. Funduscopy was performed for all the cases and the control group. RESULTS: In total, 24 eyes of 12 laser-treated ROP cases, 186 eyes of 93 spontaneously regressed ROP patients, 74 eyes of 37 premature cases with no history of ROP, and 286 eyes of 143 controls were included in the study. The mean spherical equivalent in the treated cases was not significantly different from that in the untreated cases and patients in group III. However, the average cylindrical power was significantly different among the groups (P [Formula: see text] 0.004). Furthermore, anisometropia ( [Formula: see text] 1.5 diopters) was diagnosed with a higher rate in the treated cases (P = 0.03). The corneal curvature of the laser-treated eyes was significantly steeper and the axial length was significantly shorter than those in the other groups (P [Formula: see text] 0.002 and P [Formula: see text] 0.001, respectively, for multivariate analysis). Strabismus was found in three treated patients (25%). Additionally, there were three treated eyes (12.5%) diagnosed with macular dragging. CONCLUSION: Premature cases including those who had a history of argon laser-treated ROP and those with untreated spontaneously regressed ROP showed acceptable long-term visual and refractive outcomes along with a fairly low rate of ocular disorders. PUBLISHED BY KNOWLEDGE E 2022-08-15 /pmc/articles/PMC9493422/ /pubmed/36160100 http://dx.doi.org/10.18502/jovr.v17i3.11576 Text en Copyright © 2022 Farvardin et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Farvardin, Majid
Kalantari, Zahra
Talebnejad, Mohammadreza
Alamolhoda, Marzieh
Norouzpour, Amir
Long-term Visual and Refractive Outcomes of Argon Laser-treated Retinopathy of Prematurity
title Long-term Visual and Refractive Outcomes of Argon Laser-treated Retinopathy of Prematurity
title_full Long-term Visual and Refractive Outcomes of Argon Laser-treated Retinopathy of Prematurity
title_fullStr Long-term Visual and Refractive Outcomes of Argon Laser-treated Retinopathy of Prematurity
title_full_unstemmed Long-term Visual and Refractive Outcomes of Argon Laser-treated Retinopathy of Prematurity
title_short Long-term Visual and Refractive Outcomes of Argon Laser-treated Retinopathy of Prematurity
title_sort long-term visual and refractive outcomes of argon laser-treated retinopathy of prematurity
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9493422/
https://www.ncbi.nlm.nih.gov/pubmed/36160100
http://dx.doi.org/10.18502/jovr.v17i3.11576
work_keys_str_mv AT farvardinmajid longtermvisualandrefractiveoutcomesofargonlasertreatedretinopathyofprematurity
AT kalantarizahra longtermvisualandrefractiveoutcomesofargonlasertreatedretinopathyofprematurity
AT talebnejadmohammadreza longtermvisualandrefractiveoutcomesofargonlasertreatedretinopathyofprematurity
AT alamolhodamarzieh longtermvisualandrefractiveoutcomesofargonlasertreatedretinopathyofprematurity
AT norouzpouramir longtermvisualandrefractiveoutcomesofargonlasertreatedretinopathyofprematurity